Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Szmit

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Current Oncology (Toronto, Ont.)|February 24, 2023
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung CancerMarta Olszyna-Serementa, Magdalena Zaborowska-Szmit, Sebastian Szmit, et al.
Kidney & Blood Pressure Research|June 13, 2012
Cardiovascular comorbidities for prediction of progression-free survival in patients with metastatic renal cell carcinoma treated with sorafenibSebastian Szmit, Magdalena Zaborowska, Anna Waśko-Grabowska, et al.
Journal of Clinical Medicine|September 28, 2021
Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the PandemicMaria Wieteska-Miłek, Sebastian Szmit, Michał Florczyk, et al.
Journal of the American Society of Hypertension : JASH|December 3, 2014
Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphomaSebastian Szmit, Wojciech Jurczak, Jan Maciej Zaucha, et al.
Medicine|February 1, 2020
Clinical presentation and treatment of acute coronary syndrome as well as 1-year survival of patients hospitalized due to cancer: A 7-year experience of a nonacademic centerKatarzyna Styczkiewicz, Marek Styczkiewicz, Monika Myćka, et al.
International Heart Journal|April 10, 2010
Manageability of acute severe heart failure complicated with left ventricular thrombosis during therapy for breast cancerSebastian Szmit, Marcin Kurzyna, Renata Glówczynska, et al.
Cardio-Oncology (London, England)|November 10, 2024
Venous thromboembolism is associated with increased all-cause mortality in ALK-positive non-small cell lung cancerMagdalena Zaborowska-Szmit, Sebastian Szmit, Marta Olszyna-Serementa, et al.
International Journal of Cardiology|July 19, 2018
Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamicsSzymon Darocha, Marta Banaszkiewicz, Arkadiusz Pietrasik, et al.
Advances in Respiratory Medicine|October 31, 2017
Sarcoidosis-associated pulmonary hypertension treated with sildenafil - a case reportAneta Kacprzak, Monika Szturmowicz, Barbara Burakowska, et al.
Pulmonary Circulation|June 2, 2023
Long COVID syndrome after SARS-CoV-2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionMaria Wieteska-Miłek, Beata Kuśmierczyk-Droszcz, Katarzyna Betkier-Lipińska, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Current Oncology (Toronto, Ont.)|February 24, 2023
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung CancerMarta Olszyna-Serementa, Magdalena Zaborowska-Szmit, Sebastian Szmit, et al.
Kidney & Blood Pressure Research|June 13, 2012
Cardiovascular comorbidities for prediction of progression-free survival in patients with metastatic renal cell carcinoma treated with sorafenibSebastian Szmit, Magdalena Zaborowska, Anna Waśko-Grabowska, et al.
Journal of Clinical Medicine|September 28, 2021
Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the PandemicMaria Wieteska-Miłek, Sebastian Szmit, Michał Florczyk, et al.
Journal of the American Society of Hypertension : JASH|December 3, 2014
Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphomaSebastian Szmit, Wojciech Jurczak, Jan Maciej Zaucha, et al.
Medicine|February 1, 2020
Clinical presentation and treatment of acute coronary syndrome as well as 1-year survival of patients hospitalized due to cancer: A 7-year experience of a nonacademic centerKatarzyna Styczkiewicz, Marek Styczkiewicz, Monika Myćka, et al.
International Heart Journal|April 10, 2010
Manageability of acute severe heart failure complicated with left ventricular thrombosis during therapy for breast cancerSebastian Szmit, Marcin Kurzyna, Renata Glówczynska, et al.
Cardio-Oncology (London, England)|November 10, 2024
Venous thromboembolism is associated with increased all-cause mortality in ALK-positive non-small cell lung cancerMagdalena Zaborowska-Szmit, Sebastian Szmit, Marta Olszyna-Serementa, et al.
International Journal of Cardiology|July 19, 2018
Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamicsSzymon Darocha, Marta Banaszkiewicz, Arkadiusz Pietrasik, et al.
Advances in Respiratory Medicine|October 31, 2017
Sarcoidosis-associated pulmonary hypertension treated with sildenafil - a case reportAneta Kacprzak, Monika Szturmowicz, Barbara Burakowska, et al.
Pulmonary Circulation|June 2, 2023
Long COVID syndrome after SARS-CoV-2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionMaria Wieteska-Miłek, Beata Kuśmierczyk-Droszcz, Katarzyna Betkier-Lipińska, et al.
Pageof 9